(Q30715508)

9 September 2017

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen (English)

1 reference

9 September 2017

0 references

0 references

Wei YQ

1 reference

9 September 2017

Huang MJ

1 reference

9 September 2017

Yang L

1 reference

9 September 2017

Zhao X

1 reference

9 September 2017

Tian L

1 reference

9 September 2017

Lu Y

1 reference

9 September 2017

Shu JM

1 reference

9 September 2017

Lu CJ

1 reference

9 September 2017

Niu T

1 reference

9 September 2017

Kang B

1 reference

9 September 2017

Mao YQ

1 reference

9 September 2017

Liu F

1 reference

9 September 2017

Wen YJ

1 reference

9 September 2017

Lei S

1 reference

9 September 2017

Luo F

1 reference

9 September 2017

Zhou LQ

1 reference

9 September 2017

Peng F

1 reference

9 September 2017

Jiang Y

1 reference

9 September 2017

Liu JY

1 reference

9 September 2017

Zhou H

1 reference

9 September 2017

Wang QR

1 reference

9 September 2017

He QM

1 reference

9 September 2017

Xiao F

1 reference

9 September 2017

Lou YY

1 reference

9 September 2017

Xie XJ

1 reference

9 September 2017

Li Q

1 reference

9 September 2017

Wu Y

1 reference

9 September 2017

Ding ZY

1 reference

9 September 2017

Hu B

1 reference

9 September 2017

Hu M

1 reference

9 September 2017

Zhang W

1 reference

9 September 2017

language of work or name

English

0 references

publication date

11 September 2001

1 reference

Proceedings of the National Academy of Sciences of the United States of America

9 September 2017

1 reference

inferred from page(s)

published in

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

11545-11550

1 reference

Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Immunity against cancer: lessons learned from melanoma.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Angiogenesis in cancer and other diseases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Vascular-specific growth factors and blood vessel formation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

The Drosophila genome sequence: implications for biology and medicine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Coupling and uncoupling of tumor immunity and autoimmunity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Clinical applications of angiogenic growth factors and their inhibitors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Inducing autoimmune disease to treat cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Distinct dendritic cell subsets differentially regulate the class of immune response in vivo

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Tumor immunity and autoimmunity induced by immunization with homologous DNA

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Interleukin-6 in multiple myeloma and related plasma cell dyscrasias

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Angiogenesis and tumor metastasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Tumor antigens recognized by T cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Cancer vaccines based on the identification of genes encoding cancer regression antigens

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Mechanisms of angiogenesis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

T cell selection and autoimmunity: flexibility and tuning

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Gene therapy for cancer: what have we done and where are we going?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

The expanding universe of T-cell subsets: Th1, Th2 and more.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

The implications of angiogenesis for the biology and therapy of cancer metastasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Vascular endothelial growth factor is a secreted angiogenic mitogen

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

What Is the Evidence That Tumors Are Angiogenesis Dependent?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Simultaneous blockage of different EGF-like growth factors results in efficient growth inhibition of human colon carcinoma xenografts.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

CD4+ T cells, but not CD8+ T cells, are required for the development of experimental autoimmune gastritis

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Neovascularization of the Xenopus embryo.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=58766

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

25 November 2018

1 reference

12 December 2020

Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells

1 reference

12 December 2020

A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells

1 reference

12 December 2020

Induction of apoptosis by quercetin: involvement of heat shock protein

1 reference

12 December 2020

Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70

1 reference

12 December 2020

What is the role of thymidine phosphorylase in tumor angiogenesis

1 reference

12 December 2020

A cancer therapy resistant to resistance

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.191112198

1 reference

9 September 2017

0 references

1 reference

9 September 2017

PubMed publication ID

11553767

1 reference